BIZZARI JEAN-PIERRE has filed 6 insider transactions across 2 companies since June 2024.
Most recent transaction: a tax payment of 12600 shares of ADC Therapeutics SA ($ADCT) on June 13, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2025 | ADC Therapeutics SA | $ADCT | BIZZARI JEAN-PIERRE | Director | F | Common Shares | 12600 | $3.58 | 106,902.0000 | 97,159,966 | 10.54% | 0.01% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | BIZZARI JEAN-PIERRE | Director | A | Common Stock | 1045 | $0.00 | 1,045.0000 | 5,993,866 | 9999.99% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | BIZZARI JEAN-PIERRE | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 3, 2025 | ADC Therapeutics SA | $ADCT | BIZZARI JEAN-PIERRE | Director | A | Common Shares | 40000 | $0.00 | 119,502.0000 | 97,159,966 | 50.31% | 0.04% |
| June 17, 2024 | ADC Therapeutics SA | $ADCT | BIZZARI JEAN-PIERRE | Director | S | Common Shares | 6995 | $2.89 | 79,502.0000 | 81,712,166 | 8.09% | 0.01% |
| June 13, 2024 | ADC Therapeutics SA | $ADCT | BIZZARI JEAN-PIERRE | Director | A | Common Shares | 40000 | $0.00 | 86,497.0000 | 81,712,166 | 86.03% | 0.05% |